INR 261.7
(-0.04%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 11.88 Billion INR | 6.15% |
2022 | 11.19 Billion INR | -6.98% |
2021 | 12.03 Billion INR | 27.55% |
2020 | 9.43 Billion INR | 43.96% |
2019 | 6.55 Billion INR | 14.79% |
2018 | 5.7 Billion INR | 35.06% |
2017 | 4.22 Billion INR | 58.23% |
2016 | 2.67 Billion INR | -11.08% |
2015 | 3 Billion INR | -37.56% |
2014 | 4.81 Billion INR | 24.42% |
2013 | 3.86 Billion INR | 27.39% |
2012 | 3.03 Billion INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | -12.14 Billion INR | -202.18% |
2023 Q3 | - INR | -100.0% |
2023 FY | 11.88 Billion INR | 6.15% |
2023 Q1 | - INR | -100.0% |
2023 Q4 | 11.88 Billion INR | 0.0% |
2023 Q2 | 11.89 Billion INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 Q4 | 11.19 Billion INR | 0.0% |
2022 FY | 11.19 Billion INR | -6.98% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 10.43 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 9.2 Billion INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 12.03 Billion INR | 27.55% |
2021 Q4 | 12.03 Billion INR | 0.0% |
2020 Q2 | 10.17 Billion INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 FY | 9.43 Billion INR | 43.96% |
2020 Q4 | 9.43 Billion INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2019 Q2 | 6.34 Billion INR | 0.0% |
2019 Q4 | 6.55 Billion INR | 0.0% |
2019 FY | 6.55 Billion INR | 14.79% |
2019 Q3 | - INR | -100.0% |
2019 Q1 | - INR | -100.0% |
2018 Q2 | 5.45 Billion INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q4 | 5.7 Billion INR | 0.0% |
2018 FY | 5.7 Billion INR | 35.06% |
2018 Q1 | - INR | -100.0% |
2017 Q1 | - INR | -100.0% |
2017 Q2 | 2.85 Billion INR | 0.0% |
2017 Q4 | 4.22 Billion INR | 0.0% |
2017 FY | 4.22 Billion INR | 58.23% |
2017 Q3 | - INR | -100.0% |
2016 Q1 | - INR | -100.0% |
2016 FY | 2.67 Billion INR | -11.08% |
2016 Q4 | 2.67 Billion INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2016 Q2 | 3.13 Billion INR | 0.0% |
2015 FY | 3 Billion INR | -37.56% |
2015 Q1 | 3.92 Billion INR | -18.38% |
2015 Q4 | 3 Billion INR | 0.0% |
2014 FY | 4.81 Billion INR | 24.42% |
2014 Q2 | 4.34 Billion INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 Q4 | 4.81 Billion INR | 0.0% |
2014 Q1 | 4.34 Billion INR | 0.0% |
2013 FY | 3.86 Billion INR | 27.39% |
2012 FY | 3.03 Billion INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | -980.431% |
Bajaj Consumer Care Limited | 1.53 Billion INR | -676.635% |
BCL Industries Limited | 6.27 Billion INR | -89.465% |
Colgate-Palmolive (India) Limited | 13.22 Billion INR | 10.128% |
Cupid Limited | 186.52 Million INR | -6270.479% |
Dabur India Limited | 48.19 Billion INR | 75.345% |
Emami Limited | 8.21 Billion INR | -44.559% |
Gillette India Limited | 8.59 Billion INR | -38.253% |
Godrej Consumer Products Limited | 58.97 Billion INR | 79.851% |
Hindustan Unilever Limited | 270.76 Billion INR | 95.611% |
Honasa Consumer Limited | 5.36 Billion INR | -121.371% |
JHS Svendgaard Laboratories Limited | 271.7 Million INR | -4273.33% |
Jyothy Labs Limited | 5.9 Billion INR | -101.155% |
Kaya Limited | 5.22 Billion INR | -127.532% |
Marico Limited | 32.52 Billion INR | 63.461% |
N.K Industries Limited | 22.4 Billion INR | 46.96% |
Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | -9.648% |